NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » A new assay for quantitative detection of Aspergillus antigen

EUROIMMUN - We create solutions for your laboratory diagnostics

White Paper

A new assay for quantitative detection of Aspergillus antigen

Invasive aspergillosis (IA) is a life-threatening mycosis with a high morbidity and mortality rate in immunocompromised patients. A newly developed enzyme-linked immunosorbent assay from EUROIMMUN allows for the quantitative detection of Aspergillus antigen in patient serum or lung fluid samples, supporting early diagnosis of IA. With the option of semi-automated processing, it is especially suitable for high-throughput IA diagnostics in high-risk patients.

Download to find out more.

Download White Paper